RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
118 hedge funds and large institutions have $1.29B invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
80% less call options, than puts
Call options by funds: $388K | Put options by funds: $1.94M
Holders
118
Holding in Top 10
5
Calls
$388K
Puts
$1.94M
Top Buyers
| 1 | +$29.4M | |
| 2 | +$26.7M | |
| 3 | +$18.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$17.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$17M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$8.24M | |
| 3 | -$7.61M | |
| 4 |
Renaissance Technologies
New York
|
-$6.52M |
| 5 |
Two Sigma Investments
New York
|
-$5.06M |